FR2224154A1 - - Google Patents

Info

Publication number
FR2224154A1
FR2224154A1 FR7411680A FR7411680A FR2224154A1 FR 2224154 A1 FR2224154 A1 FR 2224154A1 FR 7411680 A FR7411680 A FR 7411680A FR 7411680 A FR7411680 A FR 7411680A FR 2224154 A1 FR2224154 A1 FR 2224154A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7411680A
Other languages
French (fr)
Other versions
FR2224154B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Manetti & Roberts Italo Brit
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of FR2224154A1 publication Critical patent/FR2224154A1/fr
Application granted granted Critical
Publication of FR2224154B1 publication Critical patent/FR2224154B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7411680A 1973-04-04 1974-04-02 Expired FR2224154B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49236/73A IT1019020B (en) 1973-04-04 1973-04-04 ARGINIA PIROGLUTAMATE AND PROCEED TO PREPARE IT

Publications (2)

Publication Number Publication Date
FR2224154A1 true FR2224154A1 (en) 1974-10-31
FR2224154B1 FR2224154B1 (en) 1977-11-04

Family

ID=11270040

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7411680A Expired FR2224154B1 (en) 1973-04-04 1974-04-02

Country Status (9)

Country Link
JP (1) JPS5221572B2 (en)
AR (1) AR203747A1 (en)
CH (1) CH592058A5 (en)
DE (1) DE2416339C3 (en)
ES (1) ES424931A1 (en)
FR (1) FR2224154B1 (en)
GB (1) GB1421089A (en)
IT (1) IT1019020B (en)
ZA (1) ZA742095B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581371A (en) * 1982-03-18 1986-04-08 Laboratori Baldacci S.P.A. Pharmaceutical composition having immunomodulating activity
EP0498268A2 (en) * 1991-02-06 1992-08-12 POLI INDUSTRIA CHIMICA S.p.A. 5-Oxo-L-proline derivatives and pharmaceutical use thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102268U (en) * 1976-01-30 1977-08-03
JPS63143376U (en) * 1987-03-10 1988-09-21
DE19520792A1 (en) * 1995-06-07 1996-12-12 Bloch Wilhelm Dr Use of nitric oxide synthase inhibitors to inhibit nasal swelling

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581371A (en) * 1982-03-18 1986-04-08 Laboratori Baldacci S.P.A. Pharmaceutical composition having immunomodulating activity
EP0498268A2 (en) * 1991-02-06 1992-08-12 POLI INDUSTRIA CHIMICA S.p.A. 5-Oxo-L-proline derivatives and pharmaceutical use thereof
EP0498268A3 (en) * 1991-02-06 1993-12-08 Poli Ind Chimica Spa 5-oxo-l-proline derivatives and pharmaceutical use thereof

Also Published As

Publication number Publication date
JPS5221572B2 (en) 1977-06-11
CH592058A5 (en) 1977-10-14
ES424931A1 (en) 1976-05-16
ZA742095B (en) 1975-04-30
GB1421089A (en) 1976-01-14
AR203747A1 (en) 1975-10-15
DE2416339A1 (en) 1975-02-13
DE2416339B2 (en) 1979-02-08
DE2416339C3 (en) 1979-09-27
FR2224154B1 (en) 1977-11-04
IT1019020B (en) 1977-11-10
JPS5035317A (en) 1975-04-04

Similar Documents

Publication Publication Date Title
AU465372B2 (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU465434B2 (en)
AU450229B2 (en)
AU476714B2 (en)
AU466283B2 (en)
AU476696B2 (en)
AU472848B2 (en)
FR2224154B1 (en)
AU477823B2 (en)
AU471461B2 (en)
AU477824B2 (en)
AU461342B2 (en)
CH564481A5 (en)
AU479562A (en)
CH564845A5 (en)
CH564719A5 (en)
AU479453A (en)
CH561827A5 (en)
CH561642A5 (en)
AU479420A (en)